Sero-prevalence of herpes simplex virus type-2 among cancer cervix patients.
Serum samples were collected from 140 cancer cervix patients aged between 25-60 years and also from 20 age matched, married, healthy women to serve as controls. These sera were tested for HSV-2 antibodies by ELISA test and HBsAg by RPHA test. HSV-2 antibodies were detected in 92 (65-71%) and HBsAg in 25 (17.8%) cancer cervix patients. Sera from control group were negative for HSV-2 antibodies and HBsAg.
Lakshmi
N
N
Dept. of Microbiology, S.V. Medical College, Andra Pradash, India.
Kumar
A G
AG
Anand
T
T
Reddy
B K
BK
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006561:Herpes Simplex / Q000453:epidemiology*; D018258:Herpesvirus 2, Human / Q000276:immunology; D006801:Humans; D007194:India / Q000453:epidemiology; D008403:Mass Screening; D008875:Middle Aged; D015995:Prevalence; D002583:Uterine Cervical Neoplasms / Q000382:microbiology*
D000914:Antibodies, Viral